-
-
Call more information
660-596-2224 -
Authors: Christopher M. Burkle, M.D., J.D. ASA Monitor 02 2017, Vol.81, 12-14. Each year, the ASA Committee on Professional Liability provides a report on changing trends in malpractice insurance premiums and characteristics impacting physician anesthesiologists. The Anesthesia Closed Claims Project conducted a survey of malpractice insurers from May-July 2016 on behalf of the committee. Twenty-eight medical […]
Read MoreBy blocking muscarinic receptors, some drugs already on the market could be used to prevent, or even reverse, the process of nerve degeneration common in axonopathic diseases, including diabetes. Interview with Paul Fernyhough, PhD For years, the conventional wisdom was to treat patients with diabetic peripheral neuropathy but there was no possibility of a cure. […]
Read MoreA new report published by the Centers for Disease Control and Prevention (CDC) reports preventable deaths due to opioids are far higher in rural counties compared to urban counties, and now significantly outweigh the overall national death rate. Interview with Mark Faul, PhD, MA Excess death rates from unintentional opioid overdose remain considerably higher in […]
Read MoreAccording to a new report, most criticisms of the CDC’s guidelines for opioid management of chronic noncancer pain did not include disclosures of any potential conflicts of interests with opioid manufacturers. Interviews with Caleb Alexander, MD, and Daniel B. Carr, MD In March of last year, the Centers for Disease Control and Prevention (CDC) released […]
Read MoreAuthors: Derek R. Laver, Ph.D. et al Anesthesiology 3 2017, Vol.126, 495-506. Background: Halogenated anesthetics activate cardiac ryanodine receptor 2–mediated sarcoplasmic reticulum Ca2+ release, leading to sarcoplasmic reticulum Ca2+ depletion, reduced cardiac function, and providing cell protection against ischemia-reperfusion injury. Anesthetic activation of ryanodine receptor 2 is poorly defined, leaving aspects of the protective mechanism uncertain. Methods: Ryanodine receptor 2 […]
Read MoreThe lack of pain specialists in many parts of the US has almost reached a crisis point, making the question of when and why to refer a patient especially timely. The recent Centers for Disease Control and Prevention (CDC) guidelines for opioid management suggest that clinicans should increase the frequency of follow-up visits when prescribing […]
Read MoreWhile well known as a significant factor in overall health, vitamin D deficiency could influence the occurrence of frequent headaches, especially in patients underexposed to sunlight. Given that dietary vitamin D has been identified in the development of various neurovascular diseases, such as neurocognitive decline and ischemic stroke,1,2 it was a matter of time before vitamin […]
Read MoreNew epidemiological evidence suggests that patients at greater risk of opioid abuse and misuse could be the same patients who are more likely to receive prescriptions for pain for an extended period of time. Interview with Patrick D. Quinn, PhD, and Robert J. Gatchel, PhD, ABPP With a rising rate of opioid prescribing among patients […]
Read MoreMany people regularly take nonprescription pain relievers to manage or treat minor aches and pains. Yet some of these medications, when used regularly for an extended period of time, may increase the risk of hearing loss. Interview with Brian M, Lin, MD Today, approximately 48 million Americans suffer from some form of hearing loss, and […]
Read MoreAuthors: Spaulding C and Mennuni MG., J Am Coll Cardiol 2016 Dec 20; 68:2633 A study of Danish registry data suggests that a delay of a year may be unnecessary. Current guidelines recommend delaying noncardiac surgery for at least 6 months after percutaneous coronary intervention to insert a drug-eluting stent (DES). By linking government registries, Danish investigators […]
Read More